Increscent® is Via LA's innovative biotechnology platform for the design and development of cell-targeting multimetric oligonucleotides for enhanced therapeutic potency and precision. Via LA is currently working in collaboration with drug developers to address new therapeutic targets and improve existing ones. Customizable licenses and collaboration agreements are available, including exclusive licenses for discrete fields of use. For further information on the technology and partnering/licensing opportunities, please contact